[1] |
DEVARBHAVI H, AITHAL G, TREEPRASERTSUK S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines[J]. Hepatol Int, 2021, 15(2):258-282. doi: 10.1007/s12072-021-10144-3 |
[2] |
袁琳娜, 那恒彬译, 李武. 《2021年亚太肝病学会共识指南: 药物性肝损伤》摘译[J]. 临床肝胆病杂志, 2021, 7(6):1291-1294. |
[3] |
TESCHKE R, UETRECHT J. Mechanism of idiosyncratic drug induced liver injury(DILI): unresolved basic issues[J]. Ann Transl Med, 2021, 9(8):730. doi: 10.21037/atm-2020-ubih-05 |
[4] |
TESCHKE R. Idiosyncratic DILI: Analysis of 46, 266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019[J]. Front Pharmacol, 2019, 10:730. doi: 10.3389/fphar.2019.00730 |
[5] |
中国医药生物技术协会药物性肝损伤防治技术专业委员会, 中华医学会肝病学分会药物性肝病学组, 茅益民. 中国药物性肝损伤诊治指南(2023年版)[J]. 胃肠病学, 2023, 28(7):397-431. |
[6] |
ANDRADE R J, CHALASANI N, BJORNSSON E S, et al. Drug-induced liver injury[J]. Nat Rev Dis Primers, 2019, 5:1-22. doi: 10.1038/s41572-018-0051-2 |
[7] |
LUCENA M I, SANABRIA J, GARCÍA-CORTES M, et al. Drug-induced liver injury in older people[J]. Lancet Gastroenterol Hepatol, 2020, 5(9):862-874. [. doi: 10.1016/S2468-1253(20)30006-6 |
[8] |
李彩萍. 药物性肝损伤作用机制的研究进展[J]. 中国药物与临床, 2023, 23(6):405-408. |
[9] |
LICATA A, GIAMMANCO A, MINISSALE M G, et al. Liver and statins: a critical appraisal of the evidence[J]. Curr Med Chem, 2018, 25(42):5835-5846. |
[10] |
BJÖRNSSON E, JACOBSEN E I, KALAITZAKIS E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing[J]. J Hepatol, 2012, 56(2):374-380. doi: 10.1016/j.jhep.2011.07.023 |
[11] |
ZAMOR P J, RUSSO M W. Liver function tests and statins[J]. Curr Opin Cardiol, 2011, 26(4):338-341. doi: 10.1097/HCO.0b013e328347036f |
[12] |
MEURER L, COHEN S M. Drug-induced liver injury from statins[J]. Clin Liver Dis, 2020, 24(1):107-119. doi: 10.1016/j.cld.2019.09.007 |
[13] |
BJÖRNSSON E S. Drug-induced liver injury: an overview over the most critical compounds[J]. Arch Toxicol, 2015, 89(3):327-334. doi: 10.1007/s00204-015-1456-2 |
[14] |
CHALASANI N P, MADDUR H, RUSSO M W, et al. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2021, 116(5):878-898. doi: 10.14309/ajg.0000000000001259 |